A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : SVR24

Search Conditions:
Search Keyword : SVR24
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: SVR24
Appearance Frequency: 45 time(s)
Long forms: 12

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
sustained virologic response at 24 weeks after completing treatment
(21 times)
Gastroenterology
(8 times)
HCV (15 times)
GT (4 times)
PR (4 times)
2014 Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir.
sustained virological response at week 24
(10 times)
Gastroenterology
(4 times)
HCV (4 times)
HCC (2 times)
ADRES (1 time)
2013 Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.
sustained virologic response at post-treatment week 24
(3 times)
Medicine
(1 time)
AFP (1 time)
DAA (1 time)
HCC (1 time)
2013 Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial.
SVR at 24weeks after treatment
(2 times)
Gastroenterology
(2 times)
SVR (2 times)
EV (1 time)
HCC (1 time)
2015 Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.
SVR at week 24
(2 times)
Virology
(1 time)
SVR (2 times)
ARFI (1 time)
DAAs (1 time)
2018 Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort.
Serial eGFR levels at 24 weeks after treatment
(1 time)
Medicine
(1 time)
CHC (1 time)
DAAs (1 time)
eGFR (1 time)
2020 Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment.
sustained virologic response at follow-up week 24
(1 time)
Anti-Bacterial Agents
(1 time)
GT (1 time)
HCV (1 time)
2014 Identification of the NS5B S282T resistant variant and two novel amino acid substitutions that affect replication capacity in hepatitis C virus-infected patients treated with mericitabine and danoprevir.
sustained virologic response within 24 weeks of discontinuation of treatment
(1 time)
Medicine
(1 time)
ASV (1 time)
cART (1 time)
CD4 (1 time)
2019 Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
SVR at 24 weeks
(1 time)
Drug Therapy
(1 time)
SVR (1 time)
2018 Interferon-free treatments in patients with hepatitis C genotype 3 infection in a tertiary hospital.
10  SVR at W24 off-therapy
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
ATV (1 time)
BOC (1 time)
RAL (1 time)
2016 Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study.
11  SVR rate at 24 weeks after the end of treatment
(1 time)
Communicable Diseases
(1 time)
AEs (1 time)
HCV (1 time)
HIV (1 time)
2014 Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial.
12  SVR week 24
(1 time)
Clinical Laboratory Techniques
(1 time)
CHC (1 time)
DCV/ASV (1 time)
Fib (1 time)
2018 Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.